Xu et al. [44] reported that GDF15, as a newly identified sympathetic regulator, protects against myocardial hypertrophy by inhibiting norepinephrine-induced epidermal growth factor receptor transactivation. The gene discussed is GDF15; the disease is cardiac hypertrophy.